These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11910878)

  • 21. Cancer risk in women receiving estrogen-progestin replacement therapy.
    Persson I
    Maturitas; 1996 May; 23 Suppl():S37-45. PubMed ID: 8865138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Practical guidelines for postmenopausal hormone therapy.
    Speroff L; Kenemans P; Burger HG
    Maturitas; 2005 May; 51(1):4-7. PubMed ID: 15883102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical study of the month. Benefit/risk balance of postmenopausal estrogen-progestin treatment in peril in the Women's Health Initiative study: practical attitude of the clinician].
    Gaspard U; van den Brûle F; Pintiaux A; Foidart JM
    Rev Med Liege; 2002 Aug; 57(8):556-62. PubMed ID: 12405030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
    Colditz GA
    J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
    Pfeilschifter J
    Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk assessment of the menopausal patient.
    Kothari S; Thacker HL
    Med Clin North Am; 1999 Nov; 83(6):1489-502. PubMed ID: 10584604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hormone replacement therapy and the menopause. Australian Menopause Society.
    MacLennan AH
    Med J Aust; 1991 Jul; 155(1):43-4. PubMed ID: 2067437
    [No Abstract]   [Full Text] [Related]  

  • 28. Long-term hormone replacement therapy and risk of breast cancer in postmenopausal women.
    Newcomb PA; Longnecker MP; Storer BE; Mittendorf R; Baron J; Clapp RW; Bogdan G; Willett WC
    Am J Epidemiol; 1995 Oct; 142(8):788-95. PubMed ID: 7572954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re: Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin.
    Kuller LH
    J Natl Cancer Inst; 2000 Jul; 92(13):1100-1. PubMed ID: 10880556
    [No Abstract]   [Full Text] [Related]  

  • 30. [Hormone replacement therapy in the climacteric].
    Canto de Cetina TE
    Rev Invest Clin; 1995; 47(1):49-61. PubMed ID: 7777716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.
    de Villiers TJ; Pines A; Panay N; Gambacciani M; Archer DF; Baber RJ; Davis SR; Gompel AA; Henderson VW; Langer R; Lobo RA; Plu-Bureau G; Sturdee DW;
    Climacteric; 2013 Jun; 16(3):316-37. PubMed ID: 23672656
    [No Abstract]   [Full Text] [Related]  

  • 32. A practical guide to prescribing estrogen replacement therapy.
    Corson SL
    Int J Fertil Menopausal Stud; 1995; 40(5):229-47. PubMed ID: 8556028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of menopause in women with breast cancer.
    Brzezinski A
    Isr J Med Sci; 1995; 31(2-3):163-8. PubMed ID: 7744587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Menopausal hormonal therapy and cancer risks].
    Lasserre A; Fournier A
    Gynecol Obstet Fertil; 2016; 44(7-8):424-7. PubMed ID: 27451070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polish consensus: procedure in case of estrogen deficiency in women after breast cancer therapy.
    Milewicz A; Szymański W; Ruzyłło W; Zgliczyński S; Reinfus M; Zieliński J; Debski R; Demissie M; Tworowska U
    Gynecol Endocrinol; 2002 Oct; 16(5):385-9. PubMed ID: 12587533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The menopause: benefits and risks of estrogen-progestogen replacement therapy.
    Gambrell RD
    Fertil Steril; 1982 Apr; 37(4):457-74. PubMed ID: 7040116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risks and benefits of long-term estrogen replacement therapy.
    Barrett-Connor EL
    Public Health Rep; 1989; 104 Suppl(Suppl):62-5. PubMed ID: 2517703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The European Menopause Survey 2005: women's perceptions on the menopause and postmenopausal hormone therapy.
    Genazzani AR; Schneider HP; Panay N; Nijland EA
    Gynecol Endocrinol; 2006 Jul; 22(7):369-75. PubMed ID: 16864146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women.
    Stanford JL; Weiss NS; Voigt LF; Daling JR; Habel LA; Rossing MA
    JAMA; 1995 Jul; 274(2):137-42. PubMed ID: 7596001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent concerns surrounding HRT.
    Armitage M; Nooney J; Evans S
    Clin Endocrinol (Oxf); 2003 Aug; 59(2):145-55. PubMed ID: 12864790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.